阅读说明：本技术 用于管理高糖血症及相关病况的组合物 (Compositions for managing hyperglycemia and related conditions ) 是由 M.马杰德 K.纳加布休沙纳姆 L.蒙德库尔 于 2018-12-26 设计创作，主要内容包括：公开了一种使用含有百里氢醌的组合物治疗性管理哺乳动物中高血糖的方法。更具体地,本发明公开了含有百里氢醌的组合物,其用于抑制酶α-葡糖苷酶的活性并增加哺乳动物细胞对葡萄糖的细胞摄取。在本文中也公开了百里氢醌的抗氧化、抗炎和抗糖化作用。(A method of therapeutically managing hyperglycemia in a mammal using a thymoquinol-containing composition is disclosed. More specifically, the present invention discloses compositions containing thymohydroquinone for inhibiting the activity of the enzyme alpha-glucosidase and increasing the cellular uptake of glucose by mammalian cells. Antioxidant, anti-inflammatory and anti-glycation effects of thymohydroquinone are also disclosed herein.)